{"name":"Ente Ospedaliero Ospedali Galliera","slug":"ente-ospedaliero-ospedali-galliera","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BNT162b2 mRNA Covid-19 Vaccine","genericName":"BNT162b2 mRNA Covid-19 Vaccine","slug":"bnt162b2-mrna-covid-19-vaccine","indication":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"MET","genericName":"MET","slug":"met","indication":"Type 2 diabetes mellitus","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Neridronate","genericName":"Neridronate","slug":"neridronate","indication":"Humoral hypercalcemia of malignancy","status":"phase_3"}]}],"pipeline":[{"name":"BNT162b2 mRNA Covid-19 Vaccine","genericName":"BNT162b2 mRNA Covid-19 Vaccine","slug":"bnt162b2-mrna-covid-19-vaccine","phase":"phase_2","mechanism":"BNT162b2 mRNA Covid-19 Vaccine works by instructing cells to produce a piece of the SARS-CoV-2 virus, prompting an immune response without causing the disease.","indications":["Prevention of COVID-19 disease caused by SARS-CoV-2 virus"],"catalyst":""},{"name":"MET","genericName":"MET","slug":"met","phase":"marketed","mechanism":"MET is a metformin-based antidiabetic agent that reduces hepatic glucose production and improves insulin sensitivity.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Neridronate","genericName":"Neridronate","slug":"neridronate","phase":"phase_3","mechanism":"Farnesyl pyrophosphate synthase","indications":["Humoral hypercalcemia of malignancy","Osteoporosis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"marketed":1,"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}